EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieVergleichsstudieOpen Access

Profile of People With Parkinson's Disease Treated With a Device‐Aided Therapy in Spain. A Comparative Multicenter Observational Study

Diego Santos-García iD, Ángela Solleiro, Guillermo González-Ortega iD, Pablo Mir iD, Nuria López-Ariztegui iD, Rocío García Ramos, Inés Legarda, Anna Planas-Ballvé, Deborah Alonso-Modino, Pilar Sánchez-Alonso, Iria Cabo, Marta Blázquez-Estrada und 2 weitere

Movement Disorders Clinical Practice · 2026-01 · 13 (1) · 154-172

DOI: 10.1002/mdc3.70239 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 24.07.2025. Verfasst von Diego Santos-García und 13 weiteren Autor:innen. Beteiligte Einrichtung: CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain. Hauptthemen laut MEDLINE: Parkinson Disease, Antiparkinson Agents, Deep Brain Stimulation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fundación Novoa Santos.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objective New device‐aided therapies (DATs) have emerged to treat people with Parkinson's disease (PwP). Our aim was to know which DATs were indicated by the neurologist and to compare the characteristics of the patients treated under real clinical practice in Spain in the year 2024. Patients and methods Data collected in the DATs‐PD GETM Spanish Registry were used (REDCap). This is a descriptive, observational, prospective, multicenter, clinical registry with progressive inclusion of PwP treated with a DAT in daily clinical practice conditions in more than 40 centers from Spain for 10 years. For this proposal, only data from visit V1 (indication of DAT) were analyzed, but no follow‐up data. All patients with information on DAT received until 31/DEC/2024 were included.

Results

A total of 313 PD patients (66.7 ± 9.6 years old at V2 ; 61.7% males) were treated with a DAT . The most frequent DAT was subcutaneous foslevodopa/foscarbidopa ( fLD / fCD ) (47%) followed by deep brain stimulation ( DBS ) (20.1%) and continuous subcutaneous apomorphine infusion ( CSAI ) (19.8%). Up to 23.6% had received at least one previous DAT and 47% an on‐demand therapy. Differences in age, time with fluctuations and other aspects (motor status, quality of life or activities of daily living among others) were observed between different DAT groups. Specifically, patients treated with DBS were younger and had less advanced disease, whereas those who received LECIG were the most affected.

Conclusion

Subcutaneous therapies and DBS were the most frequent DATs (86.9%) implemented in Spain in 2024. Profile differences were detected between DAT types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseAntiparkinson AgentsDeep Brain StimulationHumansMaleSpainFemaleAgedMiddle AgedProspective StudiesRegistries

Stichwörter der Autor:innen

Parkinson's diseasedeep brain stimulationdevice‐aided therapiesinfusionregistrysubcutaneous

Substanzen

Antiparkinson Agents

Autor:innen und Institutionen

  • CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
  • Grupo de Investigación en Enfermedad de Parkinson y otros Trastornos del Movimiento, INIBIC (Instituto de Investigación Biomédica de A Coruña), A Coruña, Spain.
  • Hospital San Rafael, A Coruña.
  • Fundación Degen, A Coruña, Spain.
  • Hospital Universitario de Móstoles, Madrid, Spain.
  • Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.

ORCID-Profile: Diego Santos-García, Guillermo González-Ortega, Pablo Mir, Nuria López-Ariztegui

Förderung

  • Fundación Novoa Santos

Zitieren

APA

Santos-García, D., Solleiro, Á., González-Ortega, G., Mir, P., López-Ariztegui, N., García Ramos, R., Legarda, I., Planas-Ballvé, A., Alonso-Modino, D., Sánchez-Alonso, P., Cabo, I., Blázquez-Estrada, M., Sánchez-Ferro, Á., & DATs‐PD GETM Spanish Registry Group (2026). Profile of People With Parkinson's Disease Treated With a Device‐Aided Therapy in Spain. A Comparative Multicenter Observational Study. Movement Disorders Clinical Practice, 13(1), 154-172. https://doi.org/10.1002/mdc3.70239

Vancouver

Santos-García D, Solleiro Á, González-Ortega G, Mir P, López-Ariztegui N, García Ramos R, et al. Profile of People With Parkinson's Disease Treated With a Device‐Aided Therapy in Spain. A Comparative Multicenter Observational Study. Movement Disorders Clinical Practice. 2026;13(1):154-172. doi:10.1002/mdc3.70239

BibTeX
@article{SantosGarca2026,
  author = {Santos-García, Diego and Solleiro, Ángela and González-Ortega, Guillermo and Mir, Pablo and López-Ariztegui, Nuria and García Ramos, Rocío and Legarda, Inés and Planas-Ballvé, Anna and Alonso-Modino, Deborah and Sánchez-Alonso, Pilar and Cabo, Iria and Blázquez-Estrada, Marta and Sánchez-Ferro, Álvaro and DATs‐PD GETM Spanish Registry Group, DATs‐PD GETM Spanish Registry Group},
  title = {Profile of People With Parkinson's Disease Treated With a Device‐Aided Therapy in Spain. A Comparative Multicenter Observational Study},
  journal = {Movement Disorders Clinical Practice},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {154--172},
  doi = {10.1002/mdc3.70239}
}
Kostenlos starten →